A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.

HF 620 aims to legalize the production and administration of psilocybin for individuals diagnosed with post-traumatic stress disorder. The bill establishes a regulatory framework, defining roles for qualified medical providers who can recommend psilocybin and qualified therapy providers who can administer it. It also outlines requirements for psilocybin cultivation facilities and independent testing laboratories, including strict inventory control systems and secure administration locations. These provisions are designed to ensure controlled access and oversight of psilocybin for therapeutic use.